Eli Lilly and Company: Diabetes Mellitus, Type 2 trials
The registry lists 238 Diabetes Mellitus, Type 2 studies with Eli Lilly and Company as lead sponsor. 10 are open to participants now and 156 have results posted.
Phase 1 77Phase 2 37Phase 3 87Phase 4 33No phase 7(a study in two phases counts in both)
Studies
Page 1 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskNot yet recruitingNCT07900633Phase 3
- A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesNot yet recruitingNCT07881887Phase 1
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesRecruitingNCT07881458Phase 3
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventRecruitingNCT07783802Phase 2
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesRecruitingNCT07668336Phase 3
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingRecruitingNCT07613307Phase 3
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesRecruitingNCT07282600Phase 3
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRecruitingNCT06945406Phase 1
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruitingNCT06897475Phase 2
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RecruitingNCT06739122Phase 3
- A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 DiabetesTerminatedNCT07030868Phase 2Results posted
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT06370715Phase 4Results posted
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminCompletedNCT06192108Phase 3Results posted
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 InhibitorCompletedNCT06109311Phase 3Results posted
- A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT06045221Phase 3Results posted
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 DiabetesCompletedNCT06010004Phase 3Results posted
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneCompletedNCT05971940Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)CompletedNCT05963022Phase 3Results posted
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05936151Phase 2Results posted
- A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCompletedNCT05893797Not applicableResults posted
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesCompletedNCT05872620Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)CompletedNCT05706506Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCompletedNCT05691712Phase 3Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)CompletedNCT05662332Phase 3Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT05659537Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)CompletedNCT05564039Phase 4Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsCompletedNCT05462756Phase 3Results posted
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesActive, not recruitingNCT05433584Phase 4Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeCompletedNCT05362058Phase 3Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinCompletedNCT05275400Phase 3Results posted
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothCompletedNCT05260021Phase 3Results posted
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT05086445Phase 1Results posted
- A Study of LY3502970 in Participants With Type 2 Diabetes MellitusCompletedNCT05048719Phase 2Results posted
- A Study of LY3437943 in Participants With Type 2 DiabetesCompletedNCT04867785Phase 2Results posted
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCompletedNCT04809220Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightCompletedNCT04657003Phase 3Results posted
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)CompletedNCT04605991Phase 3Results posted
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCompletedNCT04591626Phase 3Results posted
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCompletedNCT04537923Phase 3Results posted
- A Study of LY3493269 in Participants With Type 2 DiabetesCompletedNCT04515576Phase 1Results posted
- A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes MellitusCompletedNCT04450394Phase 2Results posted
- A Study of LY3502970 in Participants With Type 2 DiabetesCompletedNCT04426474Phase 1Results posted
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using TirzepatideCompletedNCT04407234Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results posted
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT04235959Phase 1Results posted
- A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaCompletedNCT04153981Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)CompletedNCT04093752Phase 3Results posted
- A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminCompletedNCT04039503Phase 3Results posted
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 DiabetesCompletedNCT03987919Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneCompletedNCT03954834Phase 3Results posted
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCompletedNCT03952143Phase 3Results posted
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03951753Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesCompletedNCT03882970Phase 3Results posted
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesCompletedNCT03861052Phase 3Results posted
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03861039Phase 3Results posted
- A Study of LY3209590 in Participants With Type 2 Diabetes MellitusCompletedNCT03736785Phase 2Results posted
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCompletedNCT03730662Phase 3Results posted
- A Study Comparing the Dulaglutide Pen and the Semaglutide PenCompletedNCT03724981Phase 4Results posted
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT03495102Phase 3Results posted
- Assessment of Mealtime Bolus Insulin BehaviorCompletedNCT03368807Results posted
- A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03341312Phase 1Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03338010Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 DiabetesCompletedNCT03322631Phase 1Results posted
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesCompletedNCT03315780Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03311724Phase 2Results posted
- A Study of LY900014 in Participants With Type 2 Diabetes MellitusCompletedNCT03305822Phase 1Results posted
- A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy ParticipantsCompletedNCT03286751Phase 1Results posted
- A Study of LY900014 Formulation at Different Injection Sites in Healthy ParticipantsCompletedNCT03232983Phase 1Results posted
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesCompletedNCT03214380Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusCompletedNCT03131687Phase 2Results posted
- A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03018938Phase 4Results posted
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCompletedNCT02973100Phase 2Results posted
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesCompletedNCT02963766Phase 3Results posted
- A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)CompletedNCT02759107Phase 1Results posted
- A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCompletedNCT02750410Phase 4Results posted
- A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCompletedNCT02703337Phase 1Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusCompletedNCT02597049Phase 3Results posted
- A Study of U-500 Insulin (LY041001) in Participants With Type 2 DiabetesTerminatedNCT02588950Phase 1Results posted
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCompletedNCT02561078Phase 3Results posted
- A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusCompletedNCT02302716Phase 3Results posted
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCompletedNCT02197520Phase 1Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesCompletedNCT02152371Phase 3Results posted
- A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCompletedNCT02132637Phase 3Results posted
- A Study of LY2409021 in Participants With Type 2 Diabetes MellitusTerminatedNCT02111096Phase 2Results posted
- A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusCompletedNCT02091362Phase 2Results posted
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02072096Phase 4Results posted
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesTerminatedNCT02020616Phase 1/2Results posted
- A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentCompletedNCT01894568Phase 3Results posted
- A Study of LY3025876 in Participants With DiabetesCompletedNCT01870297Phase 1Results posted
- A Study of LY2405319 in Participants With Type 2 DiabetesCompletedNCT01869959Phase 1Results posted
- A Study of Multiple Doses of LY2922470 in Participants With DiabetesCompletedNCT01867216Phase 1Results posted
- A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesCompletedNCT01790438Phase 3Results posted
- Study of Human Regular U-500 Insulin in Adult Participants With Type 2 DiabetesCompletedNCT01774968Phase 4Results posted
- Comparison of Insulin Mix25 Versus Mix50CompletedNCT01773473Phase 4Results posted
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)CompletedNCT01769378Phase 3Results posted
- A Single Dose Study of LY2605541 in Participants With Liver ImpairmentCompletedNCT01751399Phase 1Results posted
- A Study of LY2922083 in Healthy Participants and Participants With DiabetesCompletedNCT01748552Phase 1Results posted